Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

28. Juli 2020 08:00 ET | Quelle: Nu-Med Plus Inc.

Patent Issued for Single-Use or Short-Term Nitric Oxide Delivery Device

SALT LAKE CITY, July 28, 2020 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device company which investigates and develops applications and devices for nitric oxide delivery in the...
18. Juni 2019 08:00 ET | Quelle: Nu-Med Plus Inc.

Nu-Med Plus, Inc. Approaches Milestone FDA Application for New Nitric Oxide Medical Device Approval

SALT LAKE CITY, June 18, 2019 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology along with innovative applications in the...
05. Februar 2019 05:30 ET | Quelle: Nu-Med Plus Inc.

Nu-Med Plus, Inc. Produces New, Smaller, and Smarter Inhaled Nitric Oxide Delivery Unit for Clinical Settings

SALT LAKE CITY, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology will receive its first clinical unit...
04. Dezember 2018 08:00 ET | Quelle: Nu-Med Plus Inc.

Nu-Med Plus, Inc. President Helps Lead Call for New Innovation in Inhaled Nitric Oxide Industry

SALT LAKE CITY, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology, released an open letter from Nu-Med Plus...
14. November 2018 12:07 ET | Quelle: Nu-Med Plus Inc.

Nu-Med Plus, Inc. Advances Blood and Plasma Transfusion Technology with New Patent

Nu-Med Plus’ Proprietary Technology Aims to Increase Longevity and Safety of Banked Blood Supply and Reduce Side Effects of Blood Transfusions SALT LAKE CITY, Nov. 14, 2018 (GLOBE NEWSWIRE) --...